INSTITUTION CLINICAL TRIAL AGREEMENT SMLOUVA SE ZDRAVOTNICKÝM ZAŘÍZENÍM O PROVEDENÍ KLINICKÉHO HODNOCENÍInstitution Clinical Trial Agreement • February 28th, 2019
This Institution Clinical Trial Agreement (“Agreement”) effective as of the last date of signature (“Effective Date”) by and among: Covance Inc, a corporation of the State of Delaware, having its principal place of business 206 Carnegie Center, Princeton, New Jersey 08450, USA, and its affiliates (hereinafter referred to as “Covance”); and Oblastní nemocnice Kolín, a.s., nemocnice Středočeského kraje, Žižkova 146, 280 02 Kolín, Česká republika represented by Petre Chudomel, MD, MBA, chairmen of the Board and Igor Karen, MD, vice-chairmen of the Board, (hereinafter referred to as “Institution”) Whereas, Covance and Institution are hereinafter referred to individually as “Party” and collectively as “Parties”; Whereas, Covance is acting in its capacity as a contract research organization as defined in ICH-GCP 1.20 as an independent contractor of OMEICOS Therapeutics GmbH having its principal offices at Robert-Rössle-Straße 10 (Building 79), 13125 Berlin, Germany (“Sponsor”) to a
INSTITUTION CLINICAL TRIAL AGREEMENT SMLOUVA O PROVEDENÍ KLINICKÉHO HODNOCENÍInstitution Clinical Trial Agreement • July 30th, 2019
This Institution Clinical Trial Agreement (“Agreement”) effective as of the date defined in Section 16(a) of this Agreement (“Effective Date”) by and among: Covance Clinical and Periapproval Services Ltd, Osprey House, Westacott Way, Littlewick Green, Maidenhead, SL6 3QH, UK, XXXXXXXXXXXXXXXXXXXXXXXXX, and its affiliates (hereinafter referred to as “Covance”); and Krajska zdravotni, a.s., Sociální péče 3316/12a, 400 11 Ústí nad Labem, Czech Republic, IČO: 254 88 627, Branch Office: Krajska zdravotni, a.s. – – Masarykova nemocnice v Usti nad Labem, o.z., Socialni pece 3316/12a, 400 11 Usti nad Labem, Czech Republic, represented XXXXXXXXXXXXXXX, (hereinafter referred to as “Institution”); Whereas, Covance and Institution are hereinafter referred to individually as “Party” and collectively as “Parties”; Whereas, Covance is acting in its capacity as a contract research organization as defined in ICH-GCP 1.20 as an independent contractor of Santen SAS, 1 Rue Pierre Fontaine, Bat
INSTITUTION CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKEM HODNOCENI SE ZDRAVOTNICKÝM ZAŘÍZENÍMInstitution Clinical Trial Agreement • August 26th, 2020
This lnstitution Clinical Trial Agreement (this "Agreement") is entered into as of the "date of Tato Smlouva o klinickém hodnocení se zdravotnickým zanzením (dále jen „Smlouva") se uzavírá ke dni osledního
